Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Summary

This is a study to test the efficacy of using standard immune therapy for melanoma prior to stereotactic radiosurgery (ipilimumab induction), as compared to stereotactic radiosurgery followed by immune therapy. The study's hypothesis is that ipilimumab induction is as good as or better than controlling brain metastases as compared to stereotactic radiosurgery followed by immune therapy.

Timeline

Start

2014-04

Primary completion

2016-08

Completion

2020-07

Outcome

Outcome not reported

Stopped: “Study halted prematurely due to a change in the standard of care treatment”

Drugs

Indications